PharmGKB Blog
Tuesday, June 26, 2012

Curators' Favorite Papers

›
The current Curators' Favorite Papers are about pharmacogenomics of antidepressant drugs. Narasimhan and Lohoff review recent findings ...
Sunday, June 24, 2012

Metformin Pharmacogenomics

›
Metformin is a first line therapy for type 2 diabetes, and is one of the most commonly prescribed drugs worldwide.   We have recently writt...
Tuesday, June 19, 2012

New haplotypes available on PharmGKB

›
Haplotypes for the UGT1A3 , CYP2F1 and CHRNA5 genes are now available on www.pharmgkb.org View a list of all the genes with haplotypes...
Wednesday, June 13, 2012

CYP2C19 and clopidogrel therapy CPIC guideline endorsed by the ASHP

›
The American Society of Health-System Pharmacists (ASHP) has endorsed the CPIC guidelines for CYP2C19 genotype and clopidogrel therapy, p...
Tuesday, June 12, 2012

Curators' Favorite Papers

›
The current Curators' Favorite Papers are about rare variants, which are part of the genetic diversity within and among populations. Ke...

FDA approves new ERBB2 targeted drug

›
The FDA approved a new drug for HER2 ( ERBB2 ) positive breast cancer (June 8, 2012). Pertuzumab (Perjeta) is an antibody that targets a d...
Friday, June 8, 2012

New PGRN Featured Project and PI for the Month of June

›
The   PGRN  website is featuring a new project and investigator of the month from the PPII (Pharmacogenetics of Phase II Drug Metabolizin...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.